A Novel Small Molecule Modulator of Amyloid Pathology

Manuscript Number: 

15-1160R2

Author(s): 
Tina L. Beckett, Melissa A. Bradley-Whitman, Shuling X. Fister, Mark A. Lovell, Bert C. Lynn, M. Paul Murphy, Christopher M. Norris

Disclosures

Tina L. Beckett

  • Nothing to Disclose

Melissa A. Bradley-Whitman

  • Nothing to Disclose

Shuling X. Fister

  • Nothing to Disclose

Mark A. Lovell

  • Equity:
    Equity Ownership in CoPlex Therapeutics which provided partial funding for research in the manuscript.
    Patents/Royalties
    Pending patent for BNC-1 has been licensed by CoPlex Therapeutics
    Grants
    • Agency: 
      CoPlex Therapeutics
      Dates: 
      2012 - 2014

Bert C. Lynn

  • Equity:
    Equity Ownership in CoPlex Therapeutics which provided partial funding for research in the manuscript.
    Patents/Royalties
    Pending patent for BNC-1 has been licensed by CoPlex Therapeutics
    Grants
    • Agency: 
      CoPlex Therapeutics
      Dates: 
      2012-2014

M. Paul Murphy

  • Nothing to Disclose

Christopher M. Norris

  • Nothing to Disclose